| Financial Year |
March 31 2023 |
| Monetary Funds |
366,161,673.94 |
| Held-for-trading Financial Assets |
709,200,746.09 |
| Notes Receivable |
15,511,470.53 |
| Accounts Receivable |
892,112,175.39 |
| Advances to Suppliers |
54,735,285.28 |
| Other Receivables |
42,578,787.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
347,165,570.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,444,578.73 |
| Other Current Assets |
32,307,262.09 |
| Total Current Assets |
2,717,074,819.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
245,542,923.16 |
| Investment Properties |
9,159,559.57 |
| Fixed Assetes |
364,783,760.14 |
| Under-construction Projects |
19,448,573.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,460,560.11 |
| R&D expenses |
13,953,842.79 |
| Goodwill |
214,035.49 |
| Long-Term Deferred and Prepaid Expenses |
82,478,720.68 |
| Deferred Income Tax Assets |
114,728,375.20 |
| Other Non-Current Assets |
24,526,743.17 |
| Sub-Total of Non-Current Assets |
949,075,891.12 |
| Total Assets |
3,666,150,710.72 |
| Short-Term Loans |
78,460,688.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
280,010,329.28 |
| Accounts Payable |
332,286,153.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,068,457.40 |
| Taxes Payable |
91,427,718.80 |
| Interest Payable |
-- |
| Dividend Payable |
2,049,894.28 |
| Other payables |
139,700,505.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,040,428.35 |
| Other Current Liabilities |
661,948,519.04 |
| Sub-Total of Current Liabilities |
1,655,005,193.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
484,900.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
41,778,081.60 |
| Total Liabilities |
1,696,783,275.43 |
| Paid-In Capital(Or Share Stock) |
153,398,600.00 |
| Capital Surplus |
510,884,903.92 |
| Surplus Reserve |
146,641,565.22 |
| LESS:Treasury Stock |
14,990,392.02 |
| Undistributed Profits |
1,168,206,532.03 |
| Minority Stockholder's Interest |
5,226,226.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,964,141,209.15 |
| Owner's Equity（Stockholder's Equity） |
1,969,367,435.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,666,150,710.72 |
